Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. [electronic resource]
Producer: 20150421Description: 535-44 p. digitalISSN:- 2326-5205
- Adult
- Aged
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis -- drug therapy
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Azathioprine -- therapeutic use
- B-Lymphocytes -- immunology
- Biomarkers
- CD5 Antigens -- metabolism
- Cell Count
- Cyclophosphamide -- therapeutic use
- Disease Progression
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Rituximab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.